GLP-1 Drugs for Alcohol Cravings: Clinical Evidence Review
Comments Off on GLP-1 Drugs for Alcohol Cravings: Clinical Evidence Review
May 10, 2026
Tirzepatide alcohol cravings reduction is an emerging clinical focus in addiction medicine. This review examines the evidence supporting tirzepatide's effects on alcohol use disorder. Understanding this dual GLP-1/GIP agonist's impact may improve…
Clinical Evidence of Semaglutide in Alcohol Use Disorder
Comments Off on Clinical Evidence of Semaglutide in Alcohol Use Disorder
May 5, 2026
Semaglutide alcohol use disorder clinical evidence reveals promising reductions in alcohol consumption among severe AUD patients. This expands GLP-1 receptor agonists' role beyond metabolic effects. Understanding this evidence helps clinicians consider…
Is cannabis legalization associated with treatment completion? A study of pregnant women admitted for cannabis use in substance use treatment facilities, 2020-2022.
Comments Off on Is cannabis legalization associated with treatment completion? A study of pregnant women admitted for cannabis use in substance use treatment facilities, 2020-2022.
March 26, 2026
Pregnant women cannabis treatment completion is a critical measure in understanding recovery success amid evolving legalization. This study analyzes treatment completion rates for pregnant women admitted for cannabis use disorder from 2020 to 2022.…